Published in N Engl J Med on June 13, 1991
Genetic diversity and relationships among Streptococcus pyogenes strains expressing serotype M1 protein: recent intercontinental spread of a subclone causing episodes of invasive disease. Infect Immun (1995) 4.40
Associations between hepatitis B virus genotype and mutants and the risk of hepatocellular carcinoma. J Natl Cancer Inst (2008) 3.27
Posttranscriptional regulation of hepatitis B virus replication by the precore protein. J Virol (1997) 1.96
Genome replication, virion secretion, and e antigen expression of naturally occurring hepatitis B virus core promoter mutants. J Virol (2003) 1.79
Mutations in the pre-core region of hepatitis B virus serve to enhance the stability of the secondary structure of the pre-genome encapsidation signal. Proc Natl Acad Sci U S A (1994) 1.76
Immune tolerance split between hepatitis B virus precore and core proteins. J Virol (2005) 1.63
A function of the hepatitis B virus precore protein is to regulate the immune response to the core antigen. Proc Natl Acad Sci U S A (2004) 1.61
The hepatitis B virus core and e antigens elicit different Th cell subsets: antigen structure can affect Th cell phenotype. J Virol (1997) 1.48
Two core promotor mutations identified in a hepatitis B virus strain associated with fulminant hepatitis result in enhanced viral replication. J Clin Invest (1996) 1.48
Pathogenesis of hepatitis B virus infection. World J Gastroenterol (2007) 1.47
Enhanced replication of a hepatitis B virus mutant associated with an epidemic of fulminant hepatitis. J Virol (1994) 1.44
Recent advances in the molecular biology of hepatitis B virus: mutant virus and the host response. Gut (1993) 1.39
Mutations in core nucleotide sequence of hepatitis B virus correlate with fulminant and severe hepatitis. J Clin Invest (1993) 1.38
Molecular mechanisms underlying occult hepatitis B virus infection. Clin Microbiol Rev (2012) 1.30
B cell gene signature with massive intrahepatic production of antibodies to hepatitis B core antigen in hepatitis B virus-associated acute liver failure. Proc Natl Acad Sci U S A (2010) 1.26
Induction of cytotoxic T cells to a cross-reactive epitope in the hepatitis C virus nonstructural RNA polymerase-like protein. J Virol (1992) 1.14
Hepatitis B virus genotype and basal core promoter/precore mutations are associated with hepatitis B-related acute-on-chronic liver failure without pre-existing liver cirrhosis. J Viral Hepat (2010) 1.13
Naturally occurring precore/core region mutations of hepatitis B virus genotype C related to hepatocellular carcinoma. PLoS One (2012) 1.13
Naturally occurring mutations define a novel function of the hepatitis B virus core promoter in core protein expression. J Virol (1998) 1.12
Development and characterization of a genotype 4 hepatitis E virus cell culture system using a HE-JF5/15F strain recovered from a fulminant hepatitis patient. J Clin Microbiol (2009) 1.11
Hepatitis B virus precore mutation and fulminant hepatitis in the United States. A polymerase chain reaction-based assay for the detection of specific mutation. J Clin Invest (1994) 1.09
Evidence for a base-paired region of hepatitis B virus pregenome encapsidation signal which influences the patterns of precore mutations abolishing HBe protein expression. J Virol (1993) 1.08
Hepatitis B Virus e Antigen Variants. Int J Med Sci (2005) 1.04
Hepatitis B virus infection and primary hepatocellular carcinoma. Clin Microbiol Rev (1992) 1.04
Antigenic switching of hepatitis B virus by alternative dimerization of the capsid protein. Structure (2012) 1.01
Prognostic factors and recurrence of hepatitis B-related hepatocellular carcinoma after argon-helium cryoablation: a prospective study. Clin Exp Metastasis (2009) 1.01
A population-based study to investigate host genetic factors associated with hepatitis B infection and pathogenesis in the Chinese population. BMC Infect Dis (2008) 1.00
Recent high incidence of fulminant hepatitis in Samara, Russia: molecular analysis of prevailing hepatitis B and D virus strains. J Clin Microbiol (2000) 0.97
Hepatitis B virus gene mutations in liver diseases: a report from New Delhi. PLoS One (2012) 0.96
Characterization of genotype-specific carboxyl-terminal cleavage sites of hepatitis B virus e antigen precursor and identification of furin as the candidate enzyme. J Virol (2009) 0.96
Chimeric constructs between two hepatitis B virus genomes confirm transcriptional impact of core promoter mutations and reveal multiple effects of core gene mutations. Virology (2009) 0.93
Variants of hepatitis B virus associated with fulminant liver disease. N Engl J Med (1991) 0.91
Specificity of an anti-capsid antibody associated with Hepatitis B Virus-related acute liver failure. J Struct Biol (2012) 0.89
Reactivation of viral replication after liver resection in patients infected with hepatitis B virus. Ann Surg (2001) 0.89
Hepatitis B virus genetic variants: biological properties and clinical implications. Emerg Microbes Infect (2013) 0.88
Clinical relevance of mutations in the precore genome of the hepatitis B virus. Gut (1995) 0.88
Molecular epidemiology of an outbreak of fulminant hepatitis B. J Clin Microbiol (2000) 0.88
Improved method for rapid and efficient determination of genome replication and protein expression of clinical hepatitis B virus isolates. J Clin Microbiol (2011) 0.88
Precore codon 28 stop mutation in hepatitis B virus from patients with hepatocellular carcinoma. Korean J Intern Med (1997) 0.87
Overview of hepatitis B viral replication and genetic variability. J Hepatol (2016) 0.87
Acute hepatitis in rats expressing human hepatitis B virus transgenes. Proc Natl Acad Sci U S A (1995) 0.87
Complete hepatitis B virus genome analysis in HBsAg positive mothers and their infants with fulminant hepatitis B. BMC Gastroenterol (2004) 0.86
A male patient with severe acute hepatitis who was domestically infected with a genotype H hepatitis B virus in Iwate, Japan. J Gastroenterol (2007) 0.85
Precore mutant of hepatitis B virus prevails in acute and chronic infections in an area in which hepatitis B is endemic. J Clin Microbiol (1996) 0.84
Regulation of microRNA by hepatitis B virus infection and their possible association with control of innate immunity. World J Gastroenterol (2014) 0.84
Molecular epidemiology and evolution in an outbreak of fulminant hepatitis B virus. J Clin Microbiol (2006) 0.83
Association of hepatitis B virus subgenotypes and basal core promoter/precore region variants with the clinical features of patients with acute hepatitis. J Gastroenterol (2008) 0.82
Genetic variation of hepatitis B virus and its significance for pathogenesis. World J Gastroenterol (2016) 0.82
The loss of HBeAg without precore mutation results in lower HBV DNA levels and ALT levels in chronic hepatitis B virus infection. J Gastroenterol (2009) 0.81
Initial load of hepatitis B virus (HBV), its changing profile, and precore/core promoter mutations correlate with the severity and outcome of acute HBV infection. J Gastroenterol (2007) 0.80
Efficacy of lamivudine or entecavir on acute exacerbation of chronic hepatitis B. Int J Med Sci (2011) 0.80
The G1613A mutation in the HBV genome affects HBeAg expression and viral replication through altered core promoter activity. PLoS One (2011) 0.79
Variability of the preC/C region of hepatitis B virus genotype A from a South African cohort predominantly infected with HIV. J Med Virol (2013) 0.79
Hepatitis B Virus Reactivation during Treatment with Multi-Tyrosine Kinase Inhibitor for Hepatocellular Carcinoma. Case Rep Oncol (2012) 0.79
High rate of core promoter and precore mutations in patients with chronic hepatitis B. Hepatol Int (2014) 0.79
Systemic inflammatory response syndrome strongly affects the prognosis of patients with fulminant hepatitis B. J Gastroenterol (2007) 0.78
The infection efficiency and replication ability of circularized HBV DNA optimized the linear HBV DNA in vitro and in vivo. Int J Mol Sci (2015) 0.77
Hepatitis B virus core protein sensitizes hepatocytes to tumor necrosis factor-induced apoptosis by suppression of the phosphorylation of mitogen-activated protein kinase kinase 7. J Virol (2014) 0.77
HBV reactivation in an occult HBV infection patient treated with prednisone for nephrotic syndrome: case report and literature review. BMC Infect Dis (2013) 0.76
Fulminant hepatitis B in infants. BMJ (1992) 0.75
Infectious diseases and AIDS. Postgrad Med J (1992) 0.75
HBx mutations promote hepatoma cell migration through the Wnt/β-catenin signaling pathway. Cancer Sci (2016) 0.75
Failure to incriminate hepatitis B, hepatitis C, and hepatitis E viruses in the aetiology of fulminant non-A non-B hepatitis. Gut (1995) 0.75
Retrospective study of the prevalence and clinical significance of hepatitis B virus precore and basal core promoter variants. Can J Gastroenterol Hepatol (2015) 0.75
Update of research and management of hepatitis B. J Gastroenterol (2006) 0.75
Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients. Arterioscler Thromb Vasc Biol (2000) 9.85
The Cognitive Abilities Screening Instrument (CASI): a practical test for cross-cultural epidemiological studies of dementia. Int Psychogeriatr (1994) 5.47
Phase II study of S-1, a novel oral derivative of 5-fluorouracil, in advanced gastric cancer. For the S-1 Cooperative Gastric Cancer Study Group. Oncology (2000) 3.50
Measurement of liver volume and hepatic functional reserve as a guide to decision-making in resectional surgery for hepatic tumors. Hepatology (1997) 3.28
A novel ER alpha-mannosidase-like protein accelerates ER-associated degradation. EMBO Rep (2001) 2.96
Abnormal structure and expression of p53 gene in human hepatocellular carcinoma. Proc Natl Acad Sci U S A (1990) 2.59
A phase II study of CPT-11, a new derivative of camptothecin, for previously untreated non-small-cell lung cancer. J Clin Oncol (1992) 2.58
Association of amino acid substitutions in penicillin-binding protein 3 with beta-lactam resistance in beta-lactamase-negative ampicillin-resistant Haemophilus influenzae. Antimicrob Agents Chemother (2001) 2.46
Hepatitis C virus: epidemiology and transmission. Hepatology (1997) 2.43
Circulating immune complexes and complement activation in primary biliary cirrhosis. N Engl J Med (1978) 2.30
Fluorescent cholangiography illuminating the biliary tree during laparoscopic cholecystectomy. Br J Surg (2010) 2.30
Randomized comparison of ultrasonic vs clamp transection of the liver. Arch Surg (2001) 2.25
A detailed linkage map of medaka, Oryzias latipes: comparative genomics and genome evolution. Genetics (2000) 2.19
Characterization of cell lines allowing tightly regulated expression of hepatitis C virus core protein. Virology (1996) 2.18
The pathogenesis of arthritis associated with acute hepatitis-B surface antigen-positive hepatitis. Complement activation and characterization of circulating immune complexes. J Clin Invest (1975) 2.13
Serial studies of hepatitis-associated antigen and antibody in patients receiving antitumor chemotherapy for myeloproliferative and lymphoproliferative disorders. Gastroenterology (1975) 2.08
Hepatitis B virus mutants associated with 3TC and famciclovir administration are replication defective. Hepatology (1998) 2.01
Posttranscriptional regulation of hepatitis B virus replication by the precore protein. J Virol (1997) 1.96
Cloning and characterization of a novel hepatitis B virus x binding protein that inhibits viral replication. J Virol (1998) 1.96
The increasing incidence of hepatocellular carcinoma. N Engl J Med (1999) 1.92
Hepatitis B virus X protein is not central to the viral life cycle in vitro. J Virol (1992) 1.92
The native form and maturation process of hepatitis C virus core protein. J Virol (1998) 1.91
Primary hepatocellular carcinoma. N Engl J Med (1991) 1.91
Structure and switching of bacterial flagellar filaments studied by X-ray fiber diffraction. Nat Struct Biol (1998) 1.89
Phase II study of S-1, a novel oral fluorouracil, in advanced non-small-cell lung cancer. Br J Cancer (2001) 1.81
Calcineurin pathway is required for endothelin-1-mediated protection against oxidant stress-induced apoptosis in cardiac myocytes. Circ Res (2001) 1.78
Relation of pancreatic duct hyperplasia to carcinoma. Cancer (1979) 1.78
Decreased suppressor cell activity in inflammatory bowel disease. Clin Exp Immunol (1978) 1.75
Evidence for extrathymic generation of intermediate T cell receptor cells in the liver revealed in thymectomized, irradiated mice subjected to bone marrow transplantation. J Exp Med (1995) 1.75
Normal serum ferritin concentrations in precirrhotic hemochromatosis. N Engl J Med (1976) 1.68
Cell-mediated immunity in acute and chronic hepatitis. J Clin Invest (1975) 1.63
Naturally occurring missense mutation in the polymerase gene terminating hepatitis B virus replication. J Virol (1991) 1.61
A new matrix protein family related to the nacreous layer formation of Pinctada fucata. FEBS Lett (1999) 1.60
Common dysregulation of Wnt/Frizzled receptor elements in human hepatocellular carcinoma. Br J Cancer (2008) 1.59
Clinical efficacy and safety of donepezil on cognitive and global function in patients with Alzheimer's disease. A 24-week, multicenter, double-blind, placebo-controlled study in Japan. E2020 Study Group. Dement Geriatr Cogn Disord (2001) 1.59
Cellular and humoral immune response to hepatitis B virus structural proteins in mice after DNA-based immunization. Gastroenterology (1997) 1.58
Alteration in suppressor cell activity in chronic active hepatitis. Proc Natl Acad Sci U S A (1978) 1.57
Hepatitis B transmission by dentists. JAMA (1974) 1.57
High affinity monoclonal antibodies to hepatitis B surface antigen (HBsAg) produced by somatic cell hybrids. Gastroenterology (1981) 1.55
Studies of the immunogenicity, communicability and genetic stability of oral poliovaccine administered during the winter. Am J Epidemiol (1967) 1.55
Proposal of a new prognostic model for hepatocellular carcinoma: an analysis of 403 patients. Gut (2005) 1.54
Cytoplasmic and nuclear polyglutamine aggregates in SCA6 Purkinje cells. Neurology (2001) 1.53
Biologic properties of hepatitis B viral genomes with mutations in the precore promoter and precore open reading frame. Virology (1997) 1.52
A long-term follow-up study of diabetic patients in Osaka, Japan: mortality and causes of death. Tohoku J Exp Med (1983) 1.50
Chronic pancreatitis in a child with glycogen storage disease type 1. Eur J Pediatr (1991) 1.48
Immunodiagnosis of hepatitis B with high-affinity IgM monoclonal antibodies. Proc Natl Acad Sci U S A (1981) 1.48
Two core promotor mutations identified in a hepatitis B virus strain associated with fulminant hepatitis result in enhanced viral replication. J Clin Invest (1996) 1.48
T-type calcium channel blockade as a therapeutic strategy against renal injury in rats with subtotal nephrectomy. Kidney Int (2008) 1.48
Interaction between duck hepatitis B virus and a 170-kilodalton cellular protein is mediated through a neutralizing epitope of the pre-S region and occurs during viral infection. J Virol (1995) 1.48
Reversible hyperintensity lesion on diffusion-weighted MRI in hypoglycemic coma. Neurology (2004) 1.47
Nonsuppressible insulin-like activity and thyroid hormones: major pituitary-dependent sulfation factors for chick embryo cartilage. Proc Natl Acad Sci U S A (1976) 1.45
Establishment and characterization of a new human hepatocellular carcinoma cell line. In Vitro (1984) 1.43
Evaluation of T cells as carriers for systemic measles virotherapy in the presence of antiviral antibodies. Gene Ther (2006) 1.43
Cloning and characterization of human type 2 and type 3 inositol 1,4,5-trisphosphate receptors. Receptors Channels (1994) 1.43
Erythrocyte sodium-potassium transport in hyperkalaemic and normokalaemic infants. Eur J Pediatr (1995) 1.43
Overexpression of human aspartyl(asparaginyl)beta-hydroxylase in hepatocellular carcinoma and cholangiocarcinoma. J Clin Invest (1996) 1.43
Tight clustering of human hepatitis B virus integration sites in hepatomas near a triple-stranded region. J Virol (1987) 1.42
Biologic significance of angiopoietin-2 expression in human hepatocellular carcinoma. J Clin Invest (1999) 1.42
A novel frizzled gene identified in human esophageal carcinoma mediates APC/beta-catenin signals. Proc Natl Acad Sci U S A (1998) 1.42
Fulminant hepatitis complicated by pancreatitis. Johns Hopkins Med J (1973) 1.40
Arthritis associated with intestinal-bypass procedure for morbid obesity. Complement activation and characterization of circulating cryoproteins. N Engl J Med (1976) 1.39
Organization and structure of the mouse interleukin-2 gene. Nucleic Acids Res (1984) 1.39
A case of actinic prurigo showing hypersensitivity of skin fibroblasts to ultraviolet A (UVA). Photodermatol Photoimmunol Photomed (2000) 1.38
The prevalence and interaction of human immunodeficiency virus and hepatitis B virus infections in Israeli hemophiliacs. Isr J Med Sci (1991) 1.38
Postprandial hypoglycaemia due to insulin lispro. Diabet Med (2004) 1.38
Rapid identification of low level hepatitis B-related viral genome in serum. J Clin Invest (1989) 1.37
Dissociation as a result of phosphorylation of an aggregated form of the small stress protein, hsp27. J Biol Chem (1994) 1.35
Evaluation of PCR primers to screen for Streptococcus pneumoniae isolates and beta-lactam resistance, and to detect common macrolide resistance determinants. J Antimicrob Chemother (2001) 1.33
Correlates of p53- and Fas (CD95)-mediated apoptosis in Alzheimer's disease. J Neurol Sci (1997) 1.31
Enhancement of cellular and humoral immune responses to hepatitis C virus core protein using DNA-based vaccines augmented with cytokine-expressing plasmids. J Immunol (1997) 1.30
alpha- and beta-adrenergic pathways differentially regulate cell type-specific apoptosis in rat cardiac myocytes. Circulation (1999) 1.30
Tandem repeat of a transcriptional enhancer upstream of the sterol 14alpha-demethylase gene (CYP51) in Penicillium digitatum. Appl Environ Microbiol (2000) 1.30
Specific inhibition of hepatitis C virus expression by antisense oligodeoxynucleotides. In vitro model for selection of target sequence. J Biol Chem (1994) 1.29
Coexpression of Grb7 with epidermal growth factor receptor or Her2/erbB2 in human advanced esophageal carcinoma. Cancer Res (1997) 1.27
Overexpression of human aspartyl (asparaginyl) beta-hydroxylase is associated with malignant transformation. Cancer Res (2000) 1.26
Purification and characterization of a 20-kDa protein that is highly homologous to alpha B crystallin. J Biol Chem (1994) 1.25
Depth of invasion parallels increased cyclooxygenase-2 levels in patients with gastric carcinoma. Cancer (2001) 1.24
Phototropism in Hypocotyls of Radish : II. Role of cis- and trans-Raphanusanins, and Raphanusamide in Phototropism of Radish Hypocotyls. Plant Physiol (1986) 1.24
Inhibition of hepatic regeneration in rats by acute and chronic ethanol intoxication. Gastroenterology (1979) 1.24
Isolation, characterization, and distribution of an unusual pancreatic human secretory protein. J Clin Invest (1985) 1.24
Hepatitis B virus infection in patients with idiopathic liver disease. Hepatology (1991) 1.23
Phosphorylation of GATA-4 is involved in alpha 1-adrenergic agonist-responsive transcription of the endothelin-1 gene in cardiac myocytes. J Biol Chem (2000) 1.23
Hepatitis B in an oncology unit. N Engl J Med (1974) 1.23
Monoclonal radioimmunoassays for hepatitis B surface antigen: demonstration of hepatitis B virus DNA or related sequences in serum and viral epitopes in immune complexes. Proc Natl Acad Sci U S A (1982) 1.23
Demonstration of previously undetected hepatitis B viral determinants in an Australian Aboriginal population by monoclonal anti-hbs antibody radioimmunoassays. Lancet (1982) 1.23
The major histocompatibility complex class I antigen-binding protein p88 is the product of the calnexin gene. Proc Natl Acad Sci U S A (1992) 1.22
Monoclonal IgM radioimmunoassay for hepatitis B surface antigen: high binding activity in serum that is unreactive with conventional antibodies. Proc Natl Acad Sci U S A (1982) 1.22
Impaired placentation in fetal alcohol syndrome. Placenta (2007) 1.21
Zinc-binding protein in the livers of neonatal, normal and partially hepatectomized rats. Biochem J (1978) 1.21
Defective gene in lactic acidosis: abnormal pyruvate dehydrogenase E1 alpha-subunit caused by a frame shift. Am J Hum Genet (1989) 1.20
Effect of insulin and glucagon on fulminant murine hepatitis. N Engl J Med (1976) 1.20
Chronic gestational exposure to ethanol causes insulin and IGF resistance and impairs acetylcholine homeostasis in the brain. Cell Mol Life Sci (2006) 1.19
Mitochondrial DNA damage as a mechanism of cell loss in Alzheimer's disease. Lab Invest (2000) 1.19
Recent advances in the natural history of hepatocellular carcinoma. Carcinogenesis (2008) 1.18
Transformation of Madin-Darby canine kidney (MDCK) epithelial cells by Epstein-Barr virus latent membrane protein 1 (LMP1) induces expression of Ets1 and invasive growth. Oncogene (2000) 1.18
A carboxy-terminal truncated insulin receptor substrate-1 dominant negative protein reverses the human hepatocellular carcinoma malignant phenotype. J Clin Invest (1996) 1.18
Carboxypeptidase D is an avian hepatitis B virus receptor. J Virol (1999) 1.18